Kiai Parsa
SEC Form 4 insider trading activity
Kiai Parsa has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, Kiai Parsa is listed as Director at MEDIFAST INC. Inside the rolling window, Kiai Parsa reported 4 open-market purchases totaling $1.4M in MED and no open-market sales. The largest disclosed transaction in the window is a purchase of 43,150 MED shares on Aug 26, 2026, worth $529K.
Companies traded
Other insiders at MED
Insider Buying
$1.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kiai Parsa made?
Kiai Parsa has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Kiai Parsa trade?
Kiai Parsa has filed SEC Form 4 disclosures for 1 company, including MED.
When was Kiai Parsa's most recent SEC Form 4 filing?
Kiai Parsa's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is Kiai Parsa's total buy and sell value in the current window?
Inside the rolling retention window, Kiai Parsa bought $1.4M and sold $0 based on SEC Form 4 filings.
What was Kiai Parsa's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 43,150 MED shares on 2026-08-26, worth $529K, per SEC Form 4 filings.